EcoR1 Goes Bottom-Fishing

The biopharma and life sciences hedge fund firm is betting big on companies whose stocks have plummeted after reporting bad news.

art_ecor1_073023.png

Courtesy Photo

In recent weeks, EcoR1 Capital has sharply boosted its stake in at least four of its major holdings and established a sizable new position in another company, according to recent 13G filings. Since the trades were made in July, some of them won’t show up in the firm’s second-quarter 13F filing when it’s made public around mid-August.

All

To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.

Related